You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

olverembatinib

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Philadelphia-Positive ALL Trial in Suzhou (Olverembatinib)

Not yet recruiting
  • Philadelphia-Positive ALL
  • Olverembatinib
  • Suzhou, Jiangsu, China
    First Affiliated Hospital of Soochow University
Jul 1, 2023

Trial (Olverembatinib)

Available
    • Olverembatinib
    • (no location specified)
    Nov 10, 2022

    Olverembatinib, Chronic Myeloid Leukemia, Chronic Phase, Tyrosine Kinase Inhibitors Trial in Shenzhen (olverembatinib)

    Recruiting
    • Olverembatinib
    • +2 more
    • olverembatinib
    • Shenzhen, Guangdong, China
      Shenzhen Second People's Hospital
    Jul 26, 2022

    Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Tianjin (Olverembatinib, Venetoclax, prednisone)

    Recruiting
    • Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
    • Olverembatinib
    • +3 more
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Oct 21, 2022

    Ph+ ALL Trial in China (Olverembatinib, Imatinib)

    Recruiting
    • Ph+ ALL
    • Chongqing, Chongqing, China
    • +8 more
    Sep 22, 2023